Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Rabies
Adolescents
Children
Americas
Western Pacific
Clear all
Type of publications
NITAG documentation
(6)
Systematic reviews (SYSVAC)
(5)
Topics
Available to download in languages
Regions
Americas
(6)
Western Pacific
(5)
Africa
(3)
Eastern Mediterranean
(1)
Europe
(5)
Countries
Australia
(1)
Bolivia
(1)
Canada
(2)
China
(4)
United States of America
(3)
Diseases
COVID-19
(10)
Rabies
(1)
Hepatitis A
(1)
Hepatitis B
(2)
Herpes zoster
(1)
Human papillomavirus (HPV)
(33)
Influenza
(3)
Japanese encephalitis
(3)
Meningococcal disease
(3)
Mumps
(1)
Pertussis
(2)
Rotavirus
(8)
RSV (Respiratory syncytial virus)
(2)
Varicella
(1)
Vaccine topics
Acceptance
(2)
Economic aspects
(1)
Efficacy/effectiveness
(1)
Target population
Adolescents
(6)
Children
(8)
Adults
(19)
All age groups
(22)
Healthcare workers
(8)
Parents/caregivers
(3)
Pregnant women
(7)
Risk group
(3)
Travellers
(1)
Publication date
2022
(6)
2021
(3)
2020
(1)
2018
(1)
11 results found
2022
∙
Ma, Y. Ren, J. Zheng, Y. Cai, D. Li, S. Li, Y.
Chinese parents' willingness to vaccinate their children against COVID-19: A systematic review and meta-analysis
2022
∙
Chen, Z. Peng, Y. Wu, X. Pang, B. Yang, F. Zheng, W. Liu, C. Zhang, J.
Comorbidities and complications of COVID-19 associated with disease severity, progression, and mortality in China with centralized isolation and hospitalization: A systematic review and meta-analysis
2022
∙
Cénat, J. M. Noorishad, P. G. Moshirian Farahi, S. M. M. Darius, W. P. Mesbahi, A. Onesi, O. Broussard, C. Furyk, S. E. Yaya, S. Caulley, E. Chomienne, M. H. Etowa, J. Labelle, P. R.
COVID-19 Vaccine Hesitancy and Related Factors in Canada: A Systematic Review and Meta-analysis
2022
∙
Fu, Y. Zhao, J. Wei, X. Han, P. Yang, L. Ren, T. Zhan, S. Li, L.
Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies
2022
∙
NACI
Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration
2022
∙
ATAGI
ATAGI recommendations for a booster dose of the paediatric Pfizer COVID-19 vaccine in children aged 5 to 11 years
2021
∙
Comité Nacional de Inmunización (CNI)
Vaccination, prevention against COVID in children under 12 years old in Bolivia
2021
∙
ACIP
COVID-19 Vaccines for Children
2021
∙
ACIP
Epidemiology of COVID-19 in Children and Teens
2020
∙
Zhang, J. Wu, J. Sun, X. Xue, H. Shao, J. Cai, W. Jing, Y. Yue, M. Dong, C.
Associations of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register